Rate of Change in 10-Year Atherosclerotic Cardiovascular Disease Risk and Its Implications for Primary Prevention

被引:6
|
作者
Hwang, In-Chang [1 ,2 ,3 ,4 ]
Kim, Chee Hae [5 ]
Kim, Jae-Young [6 ]
Choi, Hong-Mi [2 ,3 ,4 ]
Yoon, Yeonyee E. [2 ,3 ,4 ]
Cho, Goo-Yeong [2 ,3 ,4 ]
机构
[1] Seoul Natl Univ, Dept Internal Med, Div Cardiol, Bundang Hosp, 82 Gumi ro 173 Beon gil, Seongnam Si 13620, Gyeonggi Do, South Korea
[2] Seoul Natl Univ, Cardiovasc Ctr, Bundang Hosp, Seongnam, Gyeonggi, South Korea
[3] Seoul Natl Univ, Dept Internal Med, Div Cardiol, Bundang Hosp, Seongnam, Gyeonggi, South Korea
[4] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[5] Vet Hlth Serv Med Ctr, Seoul, South Korea
[6] Soonchunhyang Univ, Dept Stat, Bucheon Hosp, Bucheon, Gyeonggi, South Korea
关键词
cardiovascular diseases; cardiovascular risk factors; cardiovascular risk score; primary prevention; prognosis; ASSOCIATION; VALIDATION;
D O I
10.1161/HYPERTENSIONAHA.122.20678
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
BACKGROUND:Contemporary cardiovascular primary prevention is based on the assessment of the 10-year risk of atherosclerotic cardiovascular disease (ASCVD). However, the clinical implications of temporal change in the 10-year ASCVD risk estimate ( increment 10-year ASCVD risk/year) are unknown. METHODS:A total of 211 077 participants without established ASCVD and with repetitive 10-year ASCVD risk assessment at an interval of 4 to 5 years were selected from the Korean National Health Insurance Service data. The primary end point was a composite of myocardial infarction, stroke, coronary revascularization, and all-cause death. RESULTS:ASCVD event rates were proportional to the increment 10-year ASCVD risk/year regardless of the baseline 10-year ASCVD risk. Adjusted hazard ratio for ASCVD events per 1% increase in increment 10-year ASCVD risk/year was 1.53 (95% CI, 1.44-1.63), 1.24 (95% CI, 1.15-1.32), 1.18 (95% CI, 1.13-1.23), and 1.05 (95% CI, 1.00-1.10) in those with a baseline 10-year ASCVD risk of <5%, 5% to 7.5%, 7.5% to 20%, and & GE;20%, respectively. Appropriate control of risk factors, including low-density lipoprotein cholesterol, blood pressure, body mass index, exercise habits, and smoking status, was associated with lower ASCVD event rates, whereas failure to control these risk factors resulted in higher ASCVD event rates. CONCLUSIONS:The temporal change in 10-year ASCVD risk over a period of 4 to 5 years reflects success or failure in controlling major cardiovascular risk factors and indicates the risk of future ASCVD events. The increment 10-year ASCVD risk/year can be used as an indicator of primary prevention and guide the application of preventive measures.
引用
收藏
页码:1697 / 1706
页数:10
相关论文
共 50 条
  • [21] Spatial analysis of 10-year predicted risk and incident atherosclerotic cardiovascular disease: the CoLaus cohort
    Guillaume Jordan
    David Ridder
    Stephane Joost
    Peter Vollenweider
    Martin Preisig
    Pedro Marques-Vidal
    Idris Guessous
    Julien Vaucher
    Scientific Reports, 14
  • [22] Artificial intelligence-enhanced electrocardiography predicts 10-year risk of atherosclerotic cardiovascular disease
    Zhang, H.
    Sau, A.
    Patlatzoglou, K.
    Pastika, L.
    Sieliwonczyk, E.
    Gurnani, M.
    Zeidaabadi, B.
    Macierzanka, K.
    Barker, J.
    Liang, Y.
    Peters, N. S.
    Kramer, D. B.
    Waks, J. W.
    Ng, F. S.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [23] Pesticide exposures and 10-year atherosclerotic cardiovascular disease risk: Integrated epidemiological and bioinformatics analysis
    Wu, Xueyan
    Wei, Dandan
    Zhou, Yilin
    Cao, Qingqing
    Han, Guozhen
    Han, Erbao
    Chen, Zhiwei
    Guo, Yao
    Huo, Wenqian
    Wang, Chongjian
    Huang, Shan
    Zeng, Xin
    Wang, Xinlu
    Mao, Zhenxing
    JOURNAL OF HAZARDOUS MATERIALS, 2025, 485
  • [24] Artificial intelligence-enhanced electrocardiography predicts 10-year risk of atherosclerotic cardiovascular disease
    Zhang, H.
    Sau, A.
    Patlatzoglou, K.
    Pastika, L.
    Sieliwonczyk, E.
    Gurnani, M.
    Zeidaabadi, B.
    Macierzanka, K.
    Barker, J.
    Liang, Y.
    Peters, N. S.
    Kramer, D. B.
    Waks, J. W.
    Ng, F. S.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [25] Association of Hyperuricemia with 10-Year Atherosclerotic Cardiovascular Disease Risk among Chinese Adults and Elders
    Chen, Feilong
    Yuan, Li
    Xu, Tao
    Liu, Junting
    Han, Shaomei
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (11)
  • [26] Spatial analysis of 10-year predicted risk and incident atherosclerotic cardiovascular disease: the CoLaus cohort
    Jordan, Guillaume
    Ridder, David
    Joost, Stephane
    Vollenweider, Peter
    Preisig, Martin
    Marques-Vidal, Pedro
    Guessous, Idris
    Vaucher, Julien
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [27] Life's Essential 8 and 10-Year and Lifetime Risk of Atherosclerotic Cardiovascular Disease in China
    Jin, Cheng
    Li, Jianxin
    Liu, Fangchao
    Li, Xia
    Hui, Ying
    Chen, Shouhua
    Li, Furong
    Wang, Gang
    Liang, Fengchao
    Lu, Xiangfeng
    Wu, Shouling
    Gu, Dongfeng
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2023, 64 (06) : 927 - 935
  • [28] The Relationship Between Cardiovascular Health and 10-year Atherosclerotic Cardiovascular Risk in American Adults
    Grandhi, Gowtham R.
    Alebna, Pamela L.
    Armendano, Joaquin Ignacio
    Tasdighi, Erfan
    Osei, Albert D.
    Blaha, Michael J.
    Mehta, Anurag
    CIRCULATION, 2023, 148
  • [29] 10-Year Atherosclerotic Cardiovascular Disease Risk Scores in Patients With Nonalcoholic Fatty Liver Disease and Sex Differences
    Pemmasani, Gayatri
    Aronow, Wilbert
    Karagozian, Raffi
    Yandrapalli, Srikanth
    John, Savio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1090 - S1090
  • [30] Changes in the Framingham 10-year risk of cardiovascular disease and the European 10-year risk of fatal cardiovascular disease in a large untreated urban population
    Mansencal, N.
    Beauchet, A.
    Karam, C.
    De Roquefeuil, F.
    Rodon, C.
    Bourez, A.
    Dubourg, O.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1042 - 1042